Joshua Schechter - Jul 8, 2024 Form 4 Insider Report for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)

Role
Director
Signature
/s/ Aaron Perlitsh, Attorney-In-Fact for Joshua Schechter
Stock symbol
LFCR
Transactions as of
Jul 8, 2024
Transactions value $
$0
Form type
4
Date filed
7/10/2024, 07:41 PM
Previous filing
Mar 5, 2024
Next filing
Mar 4, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LFCR Common Stock Award +30K +52.02% 87.7K Jul 8, 2024 Direct F1, F2
holding LFCR Common Stock 2K Jul 8, 2024 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.
F2 Vests on earlier of the first anniversary of the grant date or the date of the annual meeting of stockholders first held in calendar year 2025, subject to potential acceleration.